| Emma Esposito, | |
|
10475 Perry Hwy Ste 106g, Wexford, PA 15090-9213 | |
| (877) 407-3422 | |
| (877) 407-4329 |
| Full Name | Emma Esposito |
|---|---|
| Gender | Female |
| Speciality | Qualified Speech Language Pathologist |
| Experience | 8 Years |
| Location | 10475 Perry Hwy Ste 106g, Wexford, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043810732 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL013792 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fox Rehabilitation Services Inc | 0143133009 | 898 |
News Archive
Switching from an antidepressant medication to psychotherapy or vice versa may improve symptoms in chronically depressed patients who prove unresponsive to their initial treatment, according to an article in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
A case study from the Swedish medical university Karolinska Institutet sheds light on the pathological course of Alzheimer's disease. The brain of the first Alzheimer's patient to display amyloids demonstrable with a PET scanner has been studied, both during progression of the disease and after death.
RSV, a virus that causes respiratory infections in infants and young children, selectively kills cancer cells while leaving healthy cells alone, researchers from the School of Medicine at The University of Texas Health Science Center San Antonio said.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs, licensing distribution of these drugs and engaged in further drug development, today announced that it has received notice of allowance from the US Patent Office of an additional patent that complements and expands its anti inflammatory patent portfolio for its lead drug Ampion.
ICON plc,, today announced it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding clinical study management services provided by the company to one of its clients in relation to two studies conducted between 2004 and 2006.
› Verified 3 days ago
| Provider Name | Fox Rehabilitation Services Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326092503 PECOS PAC ID: 0143133009 Enrollment ID: O20040220000258 |
News Archive
Switching from an antidepressant medication to psychotherapy or vice versa may improve symptoms in chronically depressed patients who prove unresponsive to their initial treatment, according to an article in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
A case study from the Swedish medical university Karolinska Institutet sheds light on the pathological course of Alzheimer's disease. The brain of the first Alzheimer's patient to display amyloids demonstrable with a PET scanner has been studied, both during progression of the disease and after death.
RSV, a virus that causes respiratory infections in infants and young children, selectively kills cancer cells while leaving healthy cells alone, researchers from the School of Medicine at The University of Texas Health Science Center San Antonio said.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs, licensing distribution of these drugs and engaged in further drug development, today announced that it has received notice of allowance from the US Patent Office of an additional patent that complements and expands its anti inflammatory patent portfolio for its lead drug Ampion.
ICON plc,, today announced it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding clinical study management services provided by the company to one of its clients in relation to two studies conducted between 2004 and 2006.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emma Esposito, 7 Carnegie Plz, Cherry Hill, NJ 08003-1000 Ph: (877) 407-3422 | Emma Esposito, 10475 Perry Hwy Ste 106g, Wexford, PA 15090-9213 Ph: (877) 407-3422 |
News Archive
Switching from an antidepressant medication to psychotherapy or vice versa may improve symptoms in chronically depressed patients who prove unresponsive to their initial treatment, according to an article in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
A case study from the Swedish medical university Karolinska Institutet sheds light on the pathological course of Alzheimer's disease. The brain of the first Alzheimer's patient to display amyloids demonstrable with a PET scanner has been studied, both during progression of the disease and after death.
RSV, a virus that causes respiratory infections in infants and young children, selectively kills cancer cells while leaving healthy cells alone, researchers from the School of Medicine at The University of Texas Health Science Center San Antonio said.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs, licensing distribution of these drugs and engaged in further drug development, today announced that it has received notice of allowance from the US Patent Office of an additional patent that complements and expands its anti inflammatory patent portfolio for its lead drug Ampion.
ICON plc,, today announced it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding clinical study management services provided by the company to one of its clients in relation to two studies conducted between 2004 and 2006.
› Verified 3 days ago
Mrs. Melissa Anne Hutzel, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5500 Brooktree Rd, Wexford, PA 15090 Phone: 800-422-6682 Fax: 888-889-9442 | |
Lisa Cunningham, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 608 Shelley Ln, Wexford, PA 15090 Phone: 304-650-6094 | |
Christine Rose Laslo, M.A.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Rehabcare, 5500 Brooktree Road, Suite 102, Wexford, PA 15090 Phone: 724-940-3468 Fax: 724-940-3969 | |
Mrs. Kathryn Rosemary Doran, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5500 Brooktree Rd, Suite102, Wexford, PA 15090 Phone: 724-941-3100 | |
Miss Jocelyn Shuber, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12300 Perry Hwy, Suite 100, Wexford, PA 15090 Phone: 724-933-4673 | |
Anna Danielle Mianzo, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12300 Perry Hwy, Wexford, PA 15090 Phone: 724-933-4673 |